WINTON GROUP Ltd Has $118,000 Stake in Tilray Inc (NASDAQ:TLRY)

WINTON GROUP Ltd boosted its holdings in Tilray Inc (NASDAQ:TLRYFree Report) by 46.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 88,401 shares of the company’s stock after acquiring an additional 28,008 shares during the quarter. WINTON GROUP Ltd’s holdings in Tilray were worth $118,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of TLRY. BNP Paribas Financial Markets grew its position in shares of Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after buying an additional 1,690,827 shares during the period. Virtu Financial LLC acquired a new position in Tilray during the fourth quarter valued at approximately $1,029,000. Point72 Asset Management L.P. bought a new stake in Tilray in the third quarter valued at approximately $1,348,000. XTX Topco Ltd raised its holdings in Tilray by 1,079.7% in the third quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock worth $495,000 after purchasing an additional 257,641 shares during the period. Finally, Alberta Investment Management Corp boosted its position in shares of Tilray by 58.2% during the fourth quarter. Alberta Investment Management Corp now owns 668,800 shares of the company’s stock worth $884,000 after purchasing an additional 246,000 shares in the last quarter. 9.35% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, Canaccord Genuity Group upped their price objective on shares of Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, January 13th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $2.70.

Get Our Latest Stock Report on Tilray

Tilray Stock Performance

Shares of TLRY opened at $0.66 on Tuesday. The firm has a market cap of $616.51 million, a P/E ratio of -2.19 and a beta of 2.13. Tilray Inc has a twelve month low of $0.58 and a twelve month high of $2.97. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The firm’s 50 day moving average price is $0.84 and its two-hundred day moving average price is $1.25.

Tilray (NASDAQ:TLRYGet Free Report) last posted its quarterly earnings data on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The company had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. On average, analysts forecast that Tilray Inc will post -0.2 EPS for the current fiscal year.

Tilray Profile

(Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

Featured Stories

Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRYFree Report).

Institutional Ownership by Quarter for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.